Multidisciplinary: pharmacogenomics

  • Email
  • Help

The European Medicines Agency’s scientific guidelines on pharmacogenomics (PG) help medicine developers prepare marketing authorisation applications for human medicines.

If you have comments on a document which is open for consultation, use the form for submission of comments on scientific guidelines.

For a complete list of scientific guidelines currently open for consultation, see Public consultations.

PG considerations during drug life cycle

Guidance on technical PG aspects

Therapeutic-specific PG guidance

Procedural guidance

How helpful is this page?

Average rating:

 Based on 54 ratings

Add your rating:

See all ratings
10 ratings
8 ratings
8 ratings
9 ratings
19 ratings
    

Tell us more